Skip to content

Study to evaluate Unani drugs in White patches

A Comparative Clinical Study on the efficacy of Safuf-i Baras and NB-UVB Phototherapy in Baras (Vitiligo) - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091114
Enrollment
150
Registered
2025-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Safuf-i Baras and Narrowband Ultraviolet B Phototherapy: Orally, Zulal only daily followed by exposure to Narrowband Ultraviolet B phototherapy locally on selected lesions on alternate

Sponsors

National Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed cases of Non-Segmental Vitiligo,any gender and age group from 18-50years. • Subjects with disease chronicity between 6 months to 2 years Subjects with less than or equal to 2 percent Body Surface Area (BSA) Subjects fulfilling the Vitiligo Extent Tensity Index (VETI) score up to a grade of tensity plus 3 Subjects who have not been taken any treatment in the past 2 weeks

Exclusion criteria

Exclusion criteria: Subjects with Mucosal and Universal variants NSV Subjects with Segmental Vitiligo/ Lip-Tip vitiligo Subjects with history of photosensitivity/photo-exaggerated dermatoses. Pregnant and Lactating Women Patients suffering from systemic, metabolic and other autoimmune diseases. Patients suffering from skin conditions like psoriasis, tinea, alopecia areata, halo nevus, pityriasis alba, melanoma and morphea.

Design outcomes

Primary

MeasureTime frame
Reduction in Vitiligo Extent Tensity Index (VETI) Reduction in Vitiligo Area Scoring Index (VASI)Timepoint: At baseline, 15th day, 30th day, 45th day and 60th day

Secondary

MeasureTime frame
Assessment of Quality of life in Vitiligo patients using DLQI (Dermatology Life Quality IndexTimepoint: At baseline and on last follow up (60th day)

Countries

India

Contacts

Public ContactDr Meenu Doni

National Institute of Unani Medicine

drmaquamri@gmail.com9341072974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026